Clinical Trials Logo
  1. Home
  2. Prostatic Hyperplasia, Benign
  3. NCT03055624

Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Prostatic Hyperplasia, Benign Clinical Trial

Official title:
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Clinical Trial Summary

Investigator-initiated study to evaluate the safety and efficacy of prostate artery embolization for the treatment lower urinary tract symptoms in patients with benign prostatic hyperplasia

Clinical Trial Description

This is a phase I/II, single center, prospective, single arm, investigational study to evaluate the safety and efficacy of prostate artery embolization (PAE) for treatment of severe lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH) in patients that have either failed or are intolerant to medical management. Once eligibility is confirmed, patients will undergo PAE with Embosphere Microspheres. Embolization will consist of a minimally invasive angiogram and treatment of the prostate arteries with the Embosphere particles to reduce blood flow to the prostate. Following treatment, patients will return for follow-up visits at 1, 6, 12, and 24 months post PAE. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03055624
Study type Interventional
Source University of California, San Diego
Contact
Status Completed
Phase N/A
Start date March 1, 2017
Completion date February 18, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT02074644 - Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia N/A
Completed NCT03653117 - Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction N/A
Active, not recruiting NCT05395299 - Prostatic Arterial Embolization With SQUID (Ethylene Vinyl Alcohol Copolymer ) N/A
Withdrawn NCT05157724 - Observational Study to Compare Two Prostate Laser Enucleation Techniques in Terms of Urinary Incontinence
Completed NCT02943070 - Rezum I Pilot Study for Benign Prostatic Hyperplasia N/A
Completed NCT02940392 - Rezum FIM Optimization Study N/A
Withdrawn NCT03669692 - Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. N/A
Completed NCT03230721 - ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH N/A
Completed NCT04383093 - Tadalafil Plus Tamsulosin for Male LUTS and ED
Not yet recruiting NCT06264414 - Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia Phase 3